Rankings
▼
Calendar
SCLX Q2 2019 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena
SCLX
Scilex Holding Company
$72M
Q2 2019 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$5M
Gross Profit
$4M
72.4% margin
Operating Income
-$35M
-659.4% margin
Net Income
-$45M
-849.1% margin
EPS (Diluted)
$-0.32
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$15M
Stock-Based Comp.
$1M
← FY 2019
All Quarters
Q3 2019 →